Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significance tests » significance test (Expand Search), significance testing (Expand Search), significance set (Expand Search)
tests decrease » costs decreased (Expand Search), teer decrease (Expand Search), visits decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significance tests » significance test (Expand Search), significance testing (Expand Search), significance set (Expand Search)
tests decrease » costs decreased (Expand Search), teer decrease (Expand Search), visits decreased (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
150
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
151
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
152
-
153
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
154
-
155
-
156
-
157
-
158
-
159
-
160